<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>jmedicalcasereports</PublisherName>
<JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 1; Issue 2</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>(Mar-Apr, 2020)</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Medical Case Reports</ArticleType>
<ArticleTitle>Successful Ozone Treatment of EBV and HSV-Related Viral Urticaria</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>6</LastPage>
<AuthorList>
<Author>
<FirstName>Giacomo</FirstName>
<LastName>Manfredi</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Dario</FirstName>
<LastName>Apuzzo</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Urticaria is a many-sided syndrome signed by itching, itchy red swelling and/or angioedema related to: parasites, autoimmune diseases, food intolerance, stress, viruses, physical and unfound causes (idiopathic). We reported the successful Ozone treatment of two cases of viral-related urticaria-angioedema. Case 1: a 49 years-old woman also suffering from Hashimoto autoimmune thyroiditis showed a significant increase of EBVNA-Ab and EBVCA-Ab IgG (>10 times the cut-off levels). The symptom VAS was 10/10 at the start, 4/10 after the third treatment and 0/10 after ten treatments; UAS7 was 42 at the start of the therapy, fifteen after 2 weeks, 0 after 5 weeks. Case 2: a 58 years-old man was treated for 5 months in hospital with steroids and omalizumab without any clinical improvement at all. He showed a significant increase of EBVNA-Ab and EBVCA-Ab and HSV1-Ab IgG (>10 and >20 times the cut-off levels respectively). The symptom VAS was 10/10 at the start, 2/10 after the third treatment, withdrawing steroid therapy, and 0/10 after the sixth treatment; the UAS7 was 42 at the start, ten after 2 weeks, 0 after 3 weeks. The treatment was the Small Ozonized Autohemo Therapy (SOAT) (10 ml of oxygen-ozone treated peripheral venous blood was reinjected into the patient’s gluteus); the treatment was repeated twice a week for 5 weeks. It’s well known the ozone is the most powerful natural mean pathogen killing, including viruses and bacteria; this chemical agent is many times more active than chlorine. The used ozone maker machine was Humazone from Humares (Salute OK, Rome) allowing precise photometric ozone concentration’s choice. SOAT of viral-related urticaria is effective thanks to antiviral action of ozone, acting as autovaccine.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>EBV,HSV,Viral Urticaria</Keywords>
<URLs>
<Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=7211&title=Successful Ozone Treatment of EBV and HSV-Related Viral Urticaria</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>Soldo-Juresa D, Radman M, Pejsa V, Bozikov V. Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema. Ann Saudi Med 2010; 30: 88-89.
Imbalzano E, Casciaro M, Quartuccio S, Minciullo PL, Cascio A, Calapai G, Gangemi S. Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc 2016; 37: 18-22.
Dreyfus DH. Serological evidence that activation of ubiquitous human herpesvirus?6 (HHV?6) plays a role in chronic idiopathic/spontaneous urticaria (CIU). Clinical and; Experimental Immunology 2016; 183: 230-238.
Zawar V, Godse K, Sankalecha S. Chronic urticaria associated with recurrent genital herpes simplex infection and success of antiviral therapy—a report of two cases. International Journal of Infectious Diseases 2010; 14: e514-e517.
Mareri A, Adler SP, Nigro G. Herpesvirus-associated acute urticaria: An age matched case-control study. PLoS One 2013; 8: e85378.
Khunda A, Kawsar M, Parkin JM, Forster GE. Successful use of valciclovir in a case of recurrent urticaria associated with genital herpes. Sex Transm Infect 2002; 78: 468.
Weston WL. Herpes-associated erythema multiforme. J Invest Dermatol 2005; 124: 15-16.
Cherrez-Ojeda I, Maurer M, Bernstein JA, Vanegas E, Felix M, Ramon GD, Ensina LF, Sousa JI, Benavides EE, Villa RC, Staffeld PL. Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America. World Allergy Organization Journal 2019; 12: 100011.
Marin-Cabanas I, Berbegal-de Gracia L, de Leand;oacute;n-Marrero F, Hispand;aacute;n P, Silvestre JF. Management of chronic spontaneous urticaria in routine clinical practice following the EAACI/GA (2) LEN/EDF/WAO guidelines. Actas Dermosifiliogr 2017; 108: 346-353.
Brosio F, Masetti G, Matteo G, Stefanati A, Gabutti G. A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile. Infection and drug resistance 2018; 11: 1401-1411.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Gimenez-Arnau A, Godse K, Goncalo M. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2018; 73: 1393-1414.
Jiao XJ and Peng X. Clinilal study of medical ozone therapy in chronic hepatitis B of 20 patients. Zhonghua shi yan. Chinese journal of experimental and clinical virology. 2008; 22: 484-485.
Bilge A and Ozturk O, Adali Y, Ustebay S. Could ozone treatment be a promising alternative for osteomyelitis? An experimental study. Acta Ortop Bras 2018; 26: 67-71.
Kekez MM and Sattar SA. A new ozone-based method for virus inactivation: preliminary study. Physics in Medicine and; Biology 1997; 42: 2027-2039.
Larini A and Bocci V. Effects of ozone on isolated peripheral blood mononuclear cells. Toxicol. In vitro 2005; 19: 55-61.
Wells KH, Latino J, Gavalchin J, Poiesz BJ. Inactivation of human immunodeficiency virus type 1 by ozone in vitro. Blood 1991; 78: 1882-1890.
Ji JH, Na CH, Qiang SZ, Jing YI, Gang QZ, Jing MI, Wei YZ, Yang SD, Ran WH, Wei WX, Wen LJ. Inactivation of Poliovirus by Ozone and the Impact of Ozone on the Viral Genome. Biomed Environ Sci 2019; 32: 324-333.
Bocci V and Paulesu L. Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes. Haematologica 1990; 75: 510-515.
Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and angioedema: an update on classification and pathogenesis. Clinic Rev Allerg Immunol 2018; 54: 88-101.
Kolkhir P, Altrichter S, Munoz M, Hawro T, Maurer M. New treatments for chronic urticaria. Annals of Allergy, Asthma and; Immunology 2019 Aug 22.
Vaughn JM, Chen YS, Lindburg K, Morales D. Inactivation of human and simian rotaviruses by ozone. Appl Environ Microbiol 1987; 53: 2218-2221.</References>
</References>
</Journal>
</Article>
</ArticleSet>